HOME >> MEDICINE >> NEWS
FDA approves Actonel for once-a-week use

Cincinnati, Ohio; Bridgewater, N.J. (May 20, 2002) - The FDA has approved a new 35 mg once-a-week dosage strength for Actonel (risedronate sodium tablets) for the prevention and treatment of postmenopausal osteoporosis. This approval offers patients the convenience of a once-a-week dosing option to manage their osteoporosis and protect their bones. It will be available in mid-June 2002, by prescription only.

Actonel 35 mg once-a-week is a valuable new tool for the treatment and prevention of postmenopausal osteoporosis, said Robert Lindsay, M.D., Ph.D., Chief of Internal Medicine at Helen Hayes Hospital, Professor of Clinical Medicine, Columbia University, and principal investigator of the Actonel once-a-week approval study. Patients and doctors always welcome effective new treatment choices, and we now have data that show once-a-week dosing of Actonel is therapeutically equivalent to daily 5 mg dosing."

The FDA based its approval on safety and efficacy data from a one-year, double-blind, multicenter study that included 1,456 postmenopausal women with osteoporosis and compared the effects of the once-a-week and daily dosing of Actonel on bone mineral density (BMD). Patients taking Actonel 35 mg once-a-week experienced a significant increase in lumbar spine BMD at 12 months versus baseline -- an increase that was similar to that achieved with the Actonel 5 mg daily dose. There was also a significant increase in BMD versus baseline at the hip at 12 months, an increase that was similar in both treatment groups.

The overall safety and tolerability profiles of Actonel 35 mg once-a-week and 5 mg daily were similar in the study. Consistent with other pivotal Actonel clinical studies, patients were not excluded based on a history of, or active, GI disease.


'"/>

Contact: Ashley Donnelly
adonnelly@hillandknowlton.com
212-885-0488
Hill and Knowlton
20-May-2002


Page: 1

Related medicine news :

1. FDA approves Pfizers Lyrica for the treatment of the two most common forms of neuropathic pain
2. FDA approves Enablex for treatment of overactive bladder
3. FDA approves Fosrenol(R) in end-stage renal disease (ESRD) patients
4. FDA approves Adderall XR (R) to treat ADHD in adults
5. FDA approves EPZICOM
6. FDA approves new labelling for Seroquel in bioplar mania
7. FDA approves Enbrel to treat psoriasis
8. FDA approves Climara Pro to treat menopause symptoms
9. FDA approves new approach to schizophrenia treatment
10. FDA approves new HIV protease inhibitor, Lexiva (TM)
11. FDA approves Wellbutrin XL(TM)

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/19/2019)... ROCK, Ark. (PRWEB) , ... February 19, 2019 ... ... acquisition of the Case Management Administrator Certification (CMAC). Originally developed and launched by ... is to measure the competence of case management administrators, managers, supervisors and leaders. ...
(Date:2/19/2019)... ... February 19, 2019 , ... Renowned eye ... has launched the first ever supplement to help support Keratoconus cornea health. ... vision loss. The supplement, KC Defense, includes specific amounts Copper (Cu) and Selenium ...
(Date:2/19/2019)... ... 19, 2019 , ... WEDI , the nation’s leading nonprofit authority on ... statutory advisor to the U.S. Department of Health and Human Services (HHS), today issued ... was issued following the release last week at the HIMSS Global Conference and Exhibition ...
(Date:2/19/2019)... ... 19, 2019 , ... In one of the first research ... a team led by a Worcester Polytechnic Institute professor found that women who ... greater weight gain during pregnancy, and weight retention after their baby is born. ...
(Date:2/19/2019)... ... February 19, 2019 , ... Dr. Alejandro Kovacs of ... or without a referral who are interested in full arch permanent replacement solutions ... places All-on-4® dental implants in Texarkana, TX, for those completely missing ...
Breaking Medicine News(10 mins):
(Date:2/19/2019)... , ... February 19, 2019 , ... ... treatment for gum disease that utilizes modern dental lasers. The Laser Assisted New ... remove bacteria and diseased tissue, the leading cause of gum disease. Dr. Farahmand ...
(Date:2/19/2019)... , ... February 19, 2019 , ... Dr. Jacqueline Subka, ... in Calabasas, California, to make an appointment at her Simi Valley office to ... tooth replacement, as they can last 20 years or longer with proper care and ...
(Date:2/19/2019)... ... February 19, 2019 , ... American Friends of Sheba Medical Center, Tel ... awareness and support for Israel’s national hospital, Sheba Medical Center, Tel HaShomer. Established in ... is the largest and most comprehensive medical center in the entire Middle East. ...
Breaking Medicine Technology:
Cached News: